Eurofarma Laboratórios

São Paulo, Brazil· Est. 1972

A leading Brazilian pharmaceutical company specializing in generics, branded drugs, and hospital products for Latin American markets.

eurofarma.com.br

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

Private Company

Funding information not available

AI Company Overview

A leading Brazilian pharmaceutical company specializing in generics, branded drugs, and hospital products for Latin American markets.

OncologyCentral Nervous SystemCardiologyInfectious Diseases

Technology Platform

The company's core capability is in pharmaceutical development and manufacturing technology for small molecules, including formulation development and process engineering for generics and complex dosage forms.

Opportunities

Growth opportunities include expanding its biosimilar portfolio, increasing exports from its Brazilian manufacturing plants, and further penetration into other Latin American markets.

Risk Factors

Key risks include intense price competition in the generics market, regulatory hurdles with Brazil's health agency ANVISA, and currency volatility in emerging markets.

Competitive Landscape

Eurofarma competes with other large Brazilian pharma companies (EMS, Aché) and multinational generics firms; its differentiation lies in its strong local manufacturing, extensive distribution network, and deep understanding of the Latin American regulatory and commercial environment.

More companies in Brazil →